Surveyed adults with Sjögren disease reported high physical and emotional symptom burden and widespread dissatisfaction with available treatments.

Satisfaction with semaglutide is mainly driven by effective weight loss despite gastrointestinal side effects.

The FDA accepted a BLA for garetosmab for adults with fibrodysplasia ossificans progressiva, following positive phase 3 results in new bone formation.

Maternal tobacco smoking during pregnancy is a risk factor for increased childhood blood pressure and hypertension.

Negative expectancies about pain and aging independently predicted 10-year worsening of pain severity and interference in older adults.

Over 45% of visits for mental health conditions are conducted by telehealth compared with 3.3% of visits for non-mental health conditions.

Treatment with SC vs IV tocilizumab led to higher long-term remission rates in GCA-associated aortitis, though imaging and glucocorticoid-sparing outcomes were similar.

Infants are exposed to a wider range of per- and polyfluoroalkyl substances before birth than previously thought.

Phase 3 trial results show combined ixekizumab and tirzepatide therapy outperforms ixekizumab alone for patients with psoriasis and obesity or overweight.

A considerable proportion of pregnant women are colonized with enterobacterales with ampicillin and ceftriaxone resistance in the US.

Efgartigimod alfa–hyaluronidase significantly improves ocular symptoms in adults with ocular myasthenia gravis, according to phase 3 trial data.

Pregnancy and breastfeeding are associated with stronger long-term cognitive ability among postmenopausal women.